心調律管理デバイスの市場規模、シェア、成長分析、製品別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

心調律管理デバイスの市場規模は2022年に188億米ドルと評価され、予測期間（2024-2031年）のCAGRは5.5%で、2023年の198億3,000万米ドルから2031年には304億4,000万米ドルに成長すると予測される

心調律管理デバイス市場は、心房細動、不整脈、心不全などの心血管疾患の罹患率の上昇に後押しされ、効果的な治療ソリューションに対する需要の高まりによって力強い成長を遂げています。この動向は、もともと心臓関連の病気にかかりやすい老年人口の拡大によってさらに増幅されています。特に機器の小型化、ワイヤレス接続、高度なアルゴリズムなどの技術進歩により、これらの機器の性能と精度が大幅に向上しています。植え込み型除細動器（ICD）、ペースメーカー、心臓再同期療法（CRT）などの革新的な治療法の登場は、心臓リズム障害の管理を一変させました。競合情勢は、Medtronic plc、Abbott Laboratories、Boston Scientific Corporation、Biotronik SE &Co.KG、St. Jude Medical, Inc.などの主要企業が、技術革新を推進し市場での地位を確保するために研究開発に多額の投資を行っています。その結果、世界の心調律管理デバイス市場は、心血管疾患の有病率の増加、継続的な技術強化、高齢者人口の増加の合流によって、成長軌道を維持すると予測されます。特に米国市場は、継続的な進歩により診断・治療能力が強化され、患者の転帰と生活の質が向上することから、今後数年間は持続的なCAGRが見込まれます。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 技術分析
• 価格分析
• バリューチェーン分析
• 市場のエコシステム
• 貿易分析
• サプライチェーン分析
• ケーススタディ分析
• 特許分析
• 顧客と購買基準の分析
• 規制情勢
• イノベーションマトリクス
• 主な投資の分析
• 主な成功要因
• 競合の程度

心調律管理デバイス市場：製品別

• 市場概要
• ペースメーカー
  • 埋め込み型
  • 外部
• 除細動器
  • 植込み型除細動器（ICD）
  • S-ICD
  • T-ICD
  • 体外式除細動器
  • 手動体外除細動器
  • 自動体外除細動器
  • ウェアラブル除細動器
  • 心臓再同期療法（CRT）
  • CRT除細動器
  • CRTペースメーカー

心調律管理デバイス市場：エンドユーザー別

• 市場概要
• 病院・クリニック
• 外来手術センター
• その他

心調律管理デバイス市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Physio-Control, Inc.（Stryker）（US）
• BIOTRONIK（Germany）
• Schiller（Switzerland）
• Medtronic（US）
• Abbott（US）
• Koninklijke Philips N.V.（Netherlands）
• Zoll Medical Corporation（US）
• Boston Scientific Corporation（US）
• Progetti Srl（Italy）
• LivaNova Plc（UK）
• Impella（ABIOMED, US）
• AngioDynamics, Inc.（US）
• MicroPort Scientific Corporation（China）
• Edwards Lifesciences Corporation（US）
• Getinge AB（Sweden）
• Synchrony Medical（US）
• Osypka AG（Germany）
• Inspire Medical Systems, Inc.（US）
• AtriCure, Inc.（US）
• Apex Medical（Taiwan）
• Biotronik SE & Co. KG（Germany）
• VivaSonic Inc.（US）

Cardiac Rhythm Management Devices Market size was valued at USD 18.80 billion in 2022 and is poised to grow from USD 19.83 billion in 2023 to USD 30.44 billion by 2031, at a CAGR of 5.5% during the forecast period (2024-2031)

The cardiac rhythm management devices market is experiencing robust growth, propelled by the rising incidence of cardiovascular conditions such as atrial fibrillation, arrhythmias, and heart failure, leading to an increased demand for effective treatment solutions. This trend is further amplified by the expanding geriatric population, which is inherently more vulnerable to heart-related ailments. Technological advancements, particularly in device miniaturization, wireless connectivity, and sophisticated algorithms, have significantly enhanced the performance and accuracy of these devices. The emergence of innovative treatments, such as implantable cardioverter-defibrillators (ICDs), pacemakers, and cardiac resynchronization therapy (CRT), has transformed the management of cardiac rhythm disorders. The competitive landscape is marked by key players such as Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, and St. Jude Medical, Inc., who are heavily investing in research and development to drive innovation and secure their market positions. As a result, the global cardiac rhythm management devices market is projected to sustain its growth trajectory, driven by a confluence of increasing cardiovascular disease prevalence, ongoing technological enhancement, and a growing older population. In particular, the U.S. market is anticipated to experience sustainable compound annual growth rate (CAGR) in the forthcoming years, with continual advancements set to bolster diagnosis and treatment capabilities, thereby enhancing overall patient outcomes and quality of life.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiac Rhythm Management Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiac Rhythm Management Devices Market Segmental Analysis

Global Cardiac Rhythm Management Devices Market is segmented by Product, End User, and region. Based on Product, the market is segmented into Pacemakers, and Defibrillators. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgery Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cardiac Rhythm Management Devices Market

The alarming rise in physical inactivity, identified as the second leading cause of death in the US, is a significant market driver for the Cardiac Rhythm Management Devices market. With sedentary lifestyles contributing to a heightened prevalence of chronic diseases such as diabetes and cardiovascular disorders, there is an increasing need for effective monitoring and management solutions. The World Health Organization's estimate of approximately 2 million deaths annually due to inactivity underscores the urgency for advanced cardiac devices. As more individuals become affected by heart conditions linked to a lack of exercise, demand for innovative cardiac rhythm management technologies is projected to surge in both developed and developing nations.

Restraints in the Cardiac Rhythm Management Devices Market

The Cardiac Rhythm Management Devices market faces significant restraints primarily due to the high costs associated with these advanced technologies, which can limit accessibility for both patients and healthcare providers, particularly in developing regions. Furthermore, the shortage of qualified healthcare professionals trained in the usage and maintenance of these devices exacerbates the issue, hindering optimal patient care and device efficacy. Additionally, the limited number of healthcare facilities capable of providing such specialized treatments further dampens market growth. Collectively, these factors contribute to a restrictive environment for market expansion in regions that critically need improved cardiac care solutions.

Market Trends of the Cardiac Rhythm Management Devices Market

The Cardiac Rhythm Management Devices market is witnessing a significant trend towards personalized medicine, emphasizing the customization of treatment strategies to align with individual patient profiles. This shift is fueled by the development of advanced devices equipped with adaptive algorithms and machine learning capabilities, which enable healthcare providers to deliver tailored therapies that enhance patient outcomes. As a result, there is growing investment in innovative technologies that can analyze real-time data and adjust treatment protocols, fostering a more precise approach to managing cardiac conditions. This trend not only improves patient engagement but also drives market growth and competitiveness within the sector.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Cardiac Rhythm Management Devices Market by Product

• Market Overview
• Pacemakers
  • Implantable
  • External
• Defibrillators
  • Implantable Cardioverter Defibrillators (ICD)
  • S-ICD
  • T-ICD
  • External Defibrillator
  • Manual External Defibrillator
  • Automatic External Defibrillator
  • Wearable Cardioverter Defibrillator
  • Cardiac Resynchronization Therapy (CRT)
  • CRT-Defibrillator
  • CRT-Pacemakers

Cardiac Rhythm Management Devices Market by End User

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others

Cardiac Rhythm Management Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Physio-Control, Inc. (Stryker) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoll Medical Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Progetti Srl (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Impella (ABIOMED, US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synchrony Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inspire Medical Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apex Medical (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VivaSonic Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments